CSCarolyn Dacey Seib

Carolyn Dacey Seib

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carolyn Dacey Seib has a total of 92 co-authors. Here are the top co-authors by number of shared publications:

  • Electron Kebebew

    Department of Surgery, Stanford University School of Medicine, Palo Alto, CA

    11 shared publications
  • Robin M. Cisco

    Department of Surgery, Stanford University School of Medicine, Palo Alto, CA

    7 shared publications
  • Insoo Suh

    Department of Surgery, New York University Grossman School of Medicine, New York, NY

    6 shared publications
  • Dana T. Lin

    Department of Surgery, Stanford University School of Medicine, Palo Alto, California

    5 shared publications
  • Insoo Suh

    Department of Surgery, NYU Langone Health, New York, NY http://twitter.com/insoosuh

    5 shared publications
  • Manjula Kurella Tamura

    Geriatric Research, Education and Clinical Center, Veterans Affairs Palo Alto, Palo Alto, California, USA

    5 shared publications

Latest Publications

  • Workforce growth without reach: National trends in access to high-volume parathyroid surgeons

    by Lia D. Delaney, Zofia Dudek, Patrick Weldon, Robin M. Cisco, Electron Kebebew, Carolyn D. Seib

  • Can large language models address unmet patient information needs and reduce provider burnout in the management of thyroid disease?

    by Rajam Raghunathan, Anna R. Jacobs, Vivek R. Sant, Lizabeth J. King, Gary Rothberger, Jason Prescott, John Allendorf, Carolyn D. Seib, Kepal N. Patel, Insoo Suh


  • Effect of Starting Dialysis Versus Continuing Medical Management on Survival and Home Time in Older Adults With Kidney Failure

    by Maria E. Montez-Rath, I-Chun Thomas, Vivek Charu, Michelle C. Odden, Carolyn D. Seib, Shipra Arya, Enrica Fung, Ann M. O’hAre, Susan P.Y. Wong, Manjula Kurella Tamura

    For older adults with kidney failure who are not referred for transplant, medical management is an alternative to dialysis. To compare survival and home time between older adults who started dialysis at an estimated glomerular filtration rate (eGFR) less than 12 mL/min/1.73 m2 and those who continued medical management. Observational cohort study using target trial emulation. U.S. Department of Veterans Affairs, 2010 to 2018. Adults aged 65 years or older with chronic kidney failure and eGFR below 12 mL/min/1.73 m2 who were not referred for transplant. Starting dialysis within 30 days versus continuing medical management. Mean survival and number of days at home. Among 20 440 adults (mean age, 77.9 years [SD, 8.8]), the median time to dialysis start was 8.0 days in the group starting dialysis and 3.0 years in the group continuing medical management. Over a 3-year horizon, the group starting dialysis survived 770 days and the group continuing medical management survived 761 days (difference, 9.3 days [95% CI, -17.4 to 30.1 days]). Compared with the group continuing medical management, the group starting dialysis had 13.6 fewer days at home (CI, 7.7 to 20.5 fewer days at home). Compared with the group continuing medical management and forgoing dialysis completely, the group starting dialysis had longer survival by 77.6 days (CI, 62.8 to 91.1 days) and 14.7 fewer days at home (CI, 11.2 to 16.5 fewer days at home). Potential for unmeasured confounding due to lack of symptom assessments at eligibility; limited generalizability to women and nonveterans. Older adults starting dialysis when their eGFR fell below 12 mL/min/1.73 m2 who were not referred for transplant had modest gains in life expectancy and less time at home. U.S. Department of Veterans Affairs and National Institutes of Health.


  • Benefits and Risks Associated With Antibiotic Prophylaxis for Thyroid Operations

    by Samuel D. Squires, Robin M. Cisco, Dana T. Lin, Amber W. Trickey, Electron Kebebew, Saurabh Gombar, Ye Yuan, Carolyn D. Seib


  • Disparities in access to high-volume parathyroid surgeons in the United States: A call to action

    by Kyla Wright, Sam Squires, Robin Cisco, Amber Trickey, Electron Kebebew, Insoo Suh, Carolyn D. Seib


  • Open Access

    Operative Management of Thyroid Disease in Older Adults

    by Jina Kim, Carolyn D Seib

    As the population ages, both domestically and globally, clinicians will increasingly find themselves navigating treatment decisions for thyroid disease in older adults. When considering surgical treatment, individualizing risk assessment is particularly important, as older patients can present with very different health profiles. While fit, independent individuals may benefit from thyroidectomy with minimal risk, those with multiple comorbidities and poor functional status are at higher risk of perioperative complications, which can have adverse health effects and detract from long-term quality of life. In order to optimize surgical outcomes for older adults, strategies for accurate risk assessment and mitigation are being explored. Surgical decision-making also should consider the characteristics of the thyroid disease being treated, given many benign thyroid disorders and some well-differentiated thyroid cancers can be appropriately managed nonoperatively without compromising longevity. Shared decision-making becomes increasingly important to respect the health priorities and optimize outcomes for older adults with thyroid disease. This review summarizes the current knowledge of thyroid surgery in older adults to help inform decision-making among patients and their physicians.


  • Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism

    by Carolyn D. Seib, Calyani Ganesan, Adam Furst, Alan C. Pao, Glenn M. Chertow, John T. Leppert, Insoo Suh, Maria E. Montez-Rath, Alex H.S. Harris, Amber W. Trickey, et al.

    Multidisciplinary guidelines recommend parathyroidectomy to slow the progression of chronic kidney disease in patients with primary hyperparathyroidism (PHPT) and an estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2. Limited data address the effect of parathyroidectomy on long-term kidney function. To compare the incidence of a sustained decline in eGFR of at least 50% among patients with PHPT treated with parathyroidectomy versus nonoperative management. Target trial emulation was done using observational data from adults with PHPT, using an extended Cox model with time-varying inverse probability weighting. Veterans Health Administration. Patients with a new biochemical diagnosis of PHPT in 2000 to 2019. Sustained decline of at least 50% from pretreatment eGFR. Among 43 697 patients with PHPT (mean age, 66.8 years), 2928 (6.7%) had a decline of at least 50% in eGFR over a median follow-up of 4.9 years. The weighted cumulative incidence of eGFR decline was 5.1% at 5 years and 10.8% at 10 years in patients managed with parathyroidectomy, compared with 5.1% and 12.0%, respectively, in those managed nonoperatively. The adjusted hazard of eGFR decline did not differ between parathyroidectomy and nonoperative management (hazard ratio [HR], 0.98 [95% CI, 0.82 to 1.16]). Subgroup analyses found no heterogeneity of treatment effect based on pretreatment kidney function. Parathyroidectomy was associated with a reduced hazard of the primary outcome among patients younger than 60 years (HR, 0.75 [CI, 0.59 to 0.93]) that was not evident among those aged 60 years or older (HR, 1.08 [CI, 0.87 to 1.34]). Analyses were done in a predominantly male cohort using observational data. Parathyroidectomy had no effect on long-term kidney function in older adults with PHPT. Potential benefits related to kidney function should not be the primary consideration for PHPT treatment decisions. National Institute on Aging.


  • Risk of Permanent Hypoparathyroidism Requiring Calcitriol Therapy in a Population-Based Cohort of Adults Older Than 65 Undergoing Total Thyroidectomy for Graves' Disease

    by Carolyn Dacey Seib, Tong Meng, Robin M. Cisco, Dana T. Lin, Elizabeth A. McAninch, Julie Chen, Manjula Kurella Tamura, Amber W. Trickey, Electron Kebebew

    Objective: Total thyroidectomy for Graves' disease (GD) is associated with rapid treatment of hyperthyroidism and low recurrence rates. However, it carries the risk of surgical complications including permanent hypoparathyroidism, which contributes to long-term impaired quality of life. The objective of this study was to determine the incidence of permanent hypoparathyroidism requiring calcitriol therapy among a population-based cohort of older adults undergoing total thyroidectomy for GD in the United States. Methods: We performed a population-based cohort study using 100% Medicare claims from beneficiaries older than 65 years with GD who underwent total thyroidectomy from 2007 to 2017. We required continuous enrollment in Medicare Parts A, B, and D for 12 months before and after surgery to ensure access to comprehensive claims data. Patients were excluded if they had a preoperative diagnosis of thyroid cancer or were on long-term preoperative calcitriol. Our primary outcome was permanent hypoparathyroidism, which was identified based on persistent use of calcitriol between 6 and 12 months following thyroidectomy. We used multivariable logistic regression to identify characteristics associated with permanent hypoparathyroidism, including patient age, sex, race/ethnicity, neighborhood disadvantage, Charlson–Deyo Comorbidity Index, urban or rural residence, and frailty. Results: We identified 4650 patients who underwent total thyroidectomy for GD during the study period and met the inclusion criteria (mean age = 72.8 years [standard deviation = 5.5], 86% female, and 79% white). Among this surgical cohort, 104 (2.2% [95% confidence interval, CI = 1.8–2.7%]) patients developed permanent hypoparathyroidism requiring calcitriol therapy. Patients who developed permanent hypoparathyroidism were on average older (mean age 74.1 vs. 72.8 years) than those who did not develop permanent hypoparathyroidism ( p = 0.04). On multivariable regression, older age was the only patient characteristic associated with permanent hypoparathyroidism (odds ratio age ≥76 years = 1.68 [CI = 1.13–2.51] compared with age 66–75 years). Conclusions: The risk of permanent hypoparathyroidism requiring calcitriol therapy among this national, U.S. population-based cohort of older adults with GD treated with total thyroidectomy was low, even when considering operations performed by a heterogeneous group of surgeons. These findings suggest that the risk of hypoparathyroidism should not be a deterrent to operative management for GD in older adults who are appropriate surgical candidates.